Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma.

Name: Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma.
Author: Carlsson, Mats

Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma. — المؤلف: Carlsson, Mats — Drug safety 20200117

المؤلف: Carlsson, Mats
النشر: Drug safety 20200117
الوصف: 769-784 p.
الموضوعات: Adolescent؛ Adult؛ Aged؛ Anaphylaxis؛ Antibodies, Monoclonal؛ Antibodies, Monoclonal, Humanized؛ Antibody Formation؛ Asthma